DOCSLIB.ORG

Table S1.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Table S1.Pdf TABLE S1 List of mRNAs found in Staufen155-HA containing mRNPs Probe Set ID Gene Symbol Gene Title 223183_at AGPAT3 1-acylglycerol-3-phosphate O-acyltransferase 3 223184_s_at AGPAT3 1-acylglycerol-3-phosphate O-acyltransferase 3 225440_at AGPAT3 1-acylglycerol-3-phosphate O-acyltransferase 3 232103_at BPNT1 3'(2'), 5'-bisphosphate nucleotidase 1 218786_at NT5DC3 5'-nucleotidase domain containing 3 227482_at ADCK1 aarF domain containing kinase 1 228490_at ABHD2 abhydrolase domain containing 2 218581_at ABHD4 abhydrolase domain containing 4 213198_at ACVR1B activin A receptor, type IB 234312_s_at ACSS2 acyl-CoA synthetase short-chain family member 2 219986_s_at ACAD10 acyl-Coenzyme A dehydrogenase family, member 10 204241_at ACOX3 acyl-Coenzyme A oxidase 3, pristanoyl 209765_at ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 1552727_s_at ADAMTS17 ADAM metallopeptidase with thrombospondin type 1 motif, 17 235649_at ADAMTS8 ADAM metallopeptidase with thrombospondin type 1 motif, 8 237159_x_at AP1S3 adaptor-related protein complex 1, sigma 3 subunit 1570032_at AP3B2 adaptor-related protein complex 3, beta 2 subunit 202399_s_at AP3S2 adaptor-related protein complex 3, sigma 2 subunit 235647_at AP4S1 Adaptor-related protein complex 4, sigma 1 subunit 203865_s_at ADARB1 adenosine deaminase, RNA-specific, B1 (RED1 homolog rat) 213245_at ADCY1 adenylate cyclase 1 (brain) 204497_at ADCY9 adenylate cyclase 9 228308_at ARF3 ADP-ribosylation factor 3 213433_at ARL3 ADP-ribosylation factor-like 3 1561274_at ADRBK2 Adrenergic, beta, receptor kinase 2 228771_at ADRBK2 adrenergic, beta, receptor kinase 2 232488_at AGXT2L2 alanine-glyoxylate aminotransferase 2-like 2 221589_s_at ALDH6A1 aldehyde dehydrogenase 6 family, member A1 221590_s_at ALDH6A1 Aldehyde dehydrogenase 6 family, member A1 205621_at ALKBH1 alkB, alkylation repair homolog 1 (E. coli) 222228_s_at ALKBH4 alkB, alkylation repair homolog 4 (E. coli) 210720_s_at APBA2BP amyloid beta (A4) precursor protein-binding, family A, member 2 binding protein 215148_s_at APBA3 amyloid beta (A4) precursor protein-binding, family A, member 3 (X11-like 2) 209462_at APLP1 amyloid beta (A4) precursor-like protein 1 223266_at ALS2CR2 amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 2 224900_at ANKFY1 ankyrin repeat and FYVE domain containing 1 227720_at ANKRD13B ankyrin repeat domain 13B 1556361_s_at ANKRD13C ankyrin repeat domain 13C 241321_at ANKRD23 Ankyrin repeat domain 23 228257_at ANKRD52 ankyrin repeat domain 52 200940_s_at RERE arginine-glutamic acid dipeptide (RE) repeats 1559121_s_at ARIH2 Ariadne homolog 2 (Drosophila) 238878_at ARX aristaless related homeobox 228944_at ALX3 Aristaless-like homeobox 3 202820_at AHR aryl hydrocarbon receptor 218115_at ASF1B ASF1 anti-silencing function 1 homolog B (S. cerevisiae) 223355_at ALG1 asparagine-linked glycosylation 1 homolog (S. cerevisiae, beta-1,4-mannosyltransferase) 203545_at ALG8 asparagine-linked glycosylation 8 homolog (S. cerevisiae, alpha-1,3-glucosyltransferase) 240008_at ARID1B AT rich interactive domain 1B (SWI1-like) 238589_s_at ATXN2 Ataxin 2 232612_s_at ATG16L1 ATG16 autophagy related 16-like 1 (S. cerevisiae) 213115_at ATG4A ATG4 autophagy related 4 homolog A (S. cerevisiae) 201854_s_at ASCIZ ATM/ATR-Substrate Chk2-Interacting Zn2+-finger protein 237400_at ATP5S ATP synthase, H+ transporting, mitochondrial F0 complex, subunit s (factor B) 209186_at ATP2A2 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 212361_s_at ATP2A2 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 212930_at ATP2B1 ATPase, Ca++ transporting, plasma membrane 1 212135_s_at ATP2B4 ATPase, Ca++ transporting, plasma membrane 4 209935_at ATP2C1 ATPase, Ca++ transporting, type 2C, member 1 212062_at ATP9A ATPase, Class II, type 9A 1554557_at ATP11B ATPase, Class VI, type 11B 228363_at BIRC4 baculoviral IAP repeat-containing 4 212312_at BCL2L1 BCL2-like 1 /// BCL2-like 1 226798_at BCL2L13 BCL2-like 13 (apoptosis facilitator) 219521_at B3GAT1 beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) 1562391_at B3GALNT2 Beta-1,3-N-acetylgalactosaminyltransferase 2 222462_s_at BACE1 beta-site APP-cleaving enzyme 1 222446_s_at BACE2 beta-site APP-cleaving enzyme 2 223023_at BET1L blocked early in transport 1 homolog (S. cerevisiae)-like 1569522_at BOLA2 BolA homolog 2 (E. coli) 243302_at BCKDHB Branched chain keto acid dehydrogenase E1, beta polypeptide (maple syrup urine disease) 218955_at BRF2 BRF2, subunit of RNA polymerase III transcription initiation factor, BRF1-like 230497_at BRUNOL5 bruno-like 5, RNA binding protein (Drosophila) 205299_s_at BTN2A2 butyrophilin, subfamily 2, member A2 40020_at CELSR3 cadherin, EGF LAG seven-pass G-type receptor 3 (flamingo homolog, Drosophila) 1561017_at CAB39L Calcium binding protein 39-like 204811_s_at CACNA2D2 calcium channel, voltage-dependent, alpha 2/delta subunit 2 218309_at CAMK2N1 calcium/calmodulin-dependent protein kinase II inhibitor 1 230706_s_at CAMK2N2 calcium/calmodulin-dependent protein kinase II inhibitor 2 212252_at CAMKK2 calcium/calmodulin-dependent protein kinase kinase 2, beta 219365_s_at CAMKV CaM kinase-like vesicle-associated 201988_s_at CREBL2 cAMP responsive element binding protein-like 2 228323_at CASC5 cancer susceptibility candidate 5 1560225_at CNR1 Cannabinoid receptor 1 (brain) 32094_at CHST3 carbohydrate (chondroitin 6) sulfotransferase 3 223978_s_at CRLS1 cardiolipin synthase 1 232198_at CRLS1 Cardiolipin synthase 1 201380_at CRTAP cartilage associated protein 227138_at CRTAP cartilage associated protein 242486_at CSNK1G1 Casein kinase 1, gamma 1 226032_at CASP2 caspase 2, apoptosis-related cysteine peptidase 208050_s_at CASP2 caspase 2, apoptosis-related cysteine peptidase 213274_s_at CTSB cathepsin B 231234_at CTSC cathepsin C 229746_x_at CEBPZ CCAAT/enhancer binding protein zeta 239719_at CD109 CD109 molecule 221556_at CDC14B CDC14 cell division cycle 14 homolog B (S. cerevisiae) 214721_x_at CDC42EP4 CDC42 effector protein (Rho GTPase binding) 4 218062_x_at CDC42EP4 CDC42 effector protein (Rho GTPase binding) 4 225531_at CABLES1 Cdk5 and Abl enzyme substrate 1 213977_s_at CIZ1 CDKN1A interacting zinc finger protein 1 1559006_at --- CDNA clone IMAGE:4304686 1559007_s_at --- CDNA clone IMAGE:4304686 238126_at --- CDNA clone IMAGE:4791585 226883_at --- CDNA clone IMAGE:4793058 1557487_at --- CDNA clone IMAGE:4797099 1568799_at --- CDNA clone IMAGE:4798168 1558605_at --- CDNA clone IMAGE:4819775 1558606_s_at --- CDNA clone IMAGE:4819775 238477_at --- CDNA clone IMAGE:4830091 228108_at --- CDNA clone IMAGE:5263177 239278_at --- CDNA clone IMAGE:5301129 242462_at --- CDNA clone IMAGE:5301514 227229_at --- CDNA clone IMAGE:5303499 1556586_x_at --- CDNA clone IMAGE:5310697 215128_at --- CDNA FLJ11682 fis, clone HEMBA1004880 226116_at --- CDNA FLJ12540 fis, clone NT2RM4000425 232107_at --- CDNA FLJ13332 fis, clone OVARC1001813 239866_at --- CDNA FLJ14392 fis, clone HEMBA1003166 217423_at --- CDNA FLJ20250 fis, clone COLF6635 235637_s_at --- CDNA FLJ23896 fis, clone LNG15157 236537_at --- CDNA FLJ23896 fis, clone LNG15157 238604_at --- CDNA FLJ25559 fis, clone JTH02834 236097_at --- CDNA FLJ25731 fis, clone TST05584 1556582_at --- CDNA FLJ25946 fis, clone JTH14258 225339_at --- CDNA FLJ26141 fis, clone TST03911 235434_at --- CDNA FLJ30141 fis, clone BRACE2000148 235224_s_at --- CDNA FLJ30383 fis, clone BRACE2008102 238824_at --- CDNA FLJ30581 fis, clone BRAWH2007069 237885_at --- CDNA FLJ30897 fis, clone FEBRA2005476 1557265_at --- CDNA FLJ31889 fis, clone NT2RP7003091 230581_at --- CDNA FLJ32217 fis, clone PLACE6003771 240928_at --- CDNA FLJ32498 fis, clone SKNSH2000319 228835_at --- CDNA FLJ33090 fis, clone TRACH2000559 228191_at --- CDNA FLJ33420 fis, clone BRACE2020028 1556194_a_at --- CDNA FLJ33585 fis, clone BRAMY2012163 228328_at --- CDNA FLJ33653 fis, clone BRAMY2024715 225710_at --- CDNA FLJ34013 fis, clone FCBBF2002111 235893_at --- CDNA FLJ34312 fis, clone FEBRA2008265 221937_at --- CDNA FLJ34482 fis, clone HLUNG2004067 64418_at --- CDNA FLJ34482 fis, clone HLUNG2004067 1565577_s_at --- CDNA FLJ34486 fis, clone HLUNG2004217 226773_at --- CDNA FLJ35131 fis, clone PLACE6008824 222900_at --- CDNA FLJ35910 fis, clone TESTI2009987 1557667_at --- CDNA FLJ36588 fis, clone TRACH2013991 226577_at --- CDNA FLJ36867 fis, clone ASTRO2016491 1556205_at --- CDNA FLJ37227 fis, clone BRAMY2000277 227193_at --- CDNA FLJ37631 fis, clone BRCOC2015944 1557383_a_at --- CDNA FLJ38112 fis, clone D3OST2002272 228650_at --- CDNA FLJ38469 fis, clone FEBRA2021892 238936_at --- CDNA FLJ39162 fis, clone OCBBF2002376 1555845_at --- CDNA FLJ39218 fis, clone OCBBF2006660 243976_at --- CDNA FLJ39332 fis, clone OCBBF2017069 235109_at --- CDNA FLJ40581 fis, clone THYMU2007729 227117_at --- CDNA FLJ40762 fis, clone TRACH2002847 227509_x_at --- CDNA FLJ40982 fis, clone UTERU2014601 242043_s_at --- CDNA FLJ40982 fis, clone UTERU2014601 212248_at MTDH CDNA FLJ41088 fis, clone ASTRO2002459 /// Metadherin 235268_at --- CDNA FLJ41128 fis, clone BRACE2018448 235027_at --- CDNA FLJ41146 fis, clone BRACE2036900 228971_at --- CDNA FLJ41216 fis, clone BRALZ2017620 225256_at --- CDNA FLJ41369 fis, clone BRCAN2006117 242691_at --- CDNA FLJ41369 fis, clone BRCAN2006117 227603_at --- CDNA FLJ41385 fis, clone BRCAN2022191 225923_at --- CDNA FLJ41394 fis, clone BRCAN2026197 229715_at --- CDNA FLJ41663 fis, clone FEBRA2027297 239231_at --- CDNA FLJ41910 fis, clone PEBLM2007834 236402_at --- CDNA FLJ42263 fis, clone TKIDN2014570 235679_at --- CDNA FLJ42928 fis, clone BRSSN2007076 243007_at
Load more

Recommended publications
  • Original Article Upregulation of HOXA13 As a Potential Tumorigenesis and Progression Promoter of LUSC Based on Qrt-PCR and Bioinformatics
    Int J Clin Exp Pathol 2017;10(10):10650-10665 www.ijcep.com /ISSN:1936-2625/IJCEP0065149 Original Article Upregulation of HOXA13 as a potential tumorigenesis and progression promoter of LUSC based on qRT-PCR and bioinformatics Rui Zhang1*, Yun Deng1*, Yu Zhang1, Gao-Qiang Zhai1, Rong-Quan He2, Xiao-Hua Hu2, Dan-Ming Wei1, Zhen-Bo Feng1, Gang Chen1 Departments of 1Pathology, 2Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China. *Equal contributors. Received September 7, 2017; Accepted September 29, 2017; Epub October 1, 2017; Published October 15, 2017 Abstract: In this study, we investigated the levels of homeobox A13 (HOXA13) and the mechanisms underlying the co-expressed genes of HOXA13 in lung squamous cancer (LUSC), the signaling pathways in which the co-ex- pressed genes of HOXA13 are involved and their functional roles in LUSC. The clinical significance of 23 paired LUSC tissues and adjacent non-tumor tissues were gathered. HOXA13 levels in LUSC were detected by quantita- tive real-time polymerase chain reaction (qRT-PCR). HOXA13 levels in LUSC from The Cancer Genome Atlas (TCGA) and Oncomine were analyzed. We performed receiver operator characteristic (ROC) curves of various clinicopath- ological features of LUSC. Co-expressed of HOXA13 were collected from MEM, cBioPortal and GEPIA. The func- tions and pathways of the most reliable overlapped genes were achieved from the Gene Otology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases, respectively. The protein-protein interaction (PPI) net- works were mapped using STRING. HOXA13 in LUSC were markedly upregulated compared with those in the non- cancerous controls as demonstrated by qRT-PCR (LUSC: 0.330±0.360; CONTROLS: 0.155±0.142; P=0.021).
    [Show full text]
  • The Title of the Article
    Mechanism-Anchored Profiling Derived from Epigenetic Networks Predicts Outcome in Acute Lymphoblastic Leukemia Xinan Yang, PhD1, Yong Huang, MD1, James L Chen, MD1, Jianming Xie, MSc2, Xiao Sun, PhD2, Yves A Lussier, MD1,3,4§ 1Center for Biomedical Informatics and Section of Genetic Medicine, Department of Medicine, The University of Chicago, Chicago, IL 60637 USA 2State Key Laboratory of Bioelectronics, Southeast University, 210096 Nanjing, P.R.China 3The University of Chicago Cancer Research Center, and The Ludwig Center for Metastasis Research, The University of Chicago, Chicago, IL 60637 USA 4The Institute for Genomics and Systems Biology, and the Computational Institute, The University of Chicago, Chicago, IL 60637 USA §Corresponding author Email addresses: XY: [email protected] YH: [email protected] JC: [email protected] JX: [email protected] XS: [email protected] YL: [email protected] - 1 - Abstract Background Current outcome predictors based on “molecular profiling” rely on gene lists selected without consideration for their molecular mechanisms. This study was designed to demonstrate that we could learn about genes related to a specific mechanism and further use this knowledge to predict outcome in patients – a paradigm shift towards accurate “mechanism-anchored profiling”. We propose a novel algorithm, PGnet, which predicts a tripartite mechanism-anchored network associated to epigenetic regulation consisting of phenotypes, genes and mechanisms. Genes termed as GEMs in this network meet all of the following criteria: (i) they are co-expressed with genes known to be involved in the biological mechanism of interest, (ii) they are also differentially expressed between distinct phenotypes relevant to the study, and (iii) as a biomodule, genes correlate with both the mechanism and the phenotype.
    [Show full text]
  • Identification of the Binding Partners for Hspb2 and Cryab Reveals
    Brigham Young University BYU ScholarsArchive Theses and Dissertations 2013-12-12 Identification of the Binding arP tners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non- Redundant Roles for Small Heat Shock Proteins Kelsey Murphey Langston Brigham Young University - Provo Follow this and additional works at: https://scholarsarchive.byu.edu/etd Part of the Microbiology Commons BYU ScholarsArchive Citation Langston, Kelsey Murphey, "Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non-Redundant Roles for Small Heat Shock Proteins" (2013). Theses and Dissertations. 3822. https://scholarsarchive.byu.edu/etd/3822 This Thesis is brought to you for free and open access by BYU ScholarsArchive. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of BYU ScholarsArchive. For more information, please contact [email protected], [email protected]. Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non-Redundant Roles for Small Heat Shock Proteins Kelsey Langston A thesis submitted to the faculty of Brigham Young University in partial fulfillment of the requirements for the degree of Master of Science Julianne H. Grose, Chair William R. McCleary Brian Poole Department of Microbiology and Molecular Biology Brigham Young University December 2013 Copyright © 2013 Kelsey Langston All Rights Reserved ABSTRACT Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactors and Non-Redundant Roles for Small Heat Shock Proteins Kelsey Langston Department of Microbiology and Molecular Biology, BYU Master of Science Small Heat Shock Proteins (sHSP) are molecular chaperones that play protective roles in cell survival and have been shown to possess chaperone activity.
    [Show full text]
  • Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-Cell Leukemia
    Author Manuscript Published OnlineFirst on March 27, 2020; DOI: 10.1158/1078-0432.CCR-19-3519 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Constitutive activation of RAS/MAPK pathway cooperates with trisomy 21 and is therapeutically exploitable in Down syndrome B-cell Leukemia Anouchka P. Laurent1,2, Aurélie Siret1, Cathy Ignacimouttou1, Kunjal Panchal3, M’Boyba K. Diop4, Silvia Jenny5, Yi-Chien Tsai5, Damien Ross-Weil1, Zakia Aid1, Naïs Prade6, Stéphanie Lagarde6, Damien Plassard7, Gaelle Pierron8, Estelle Daudigeos-Dubus4, Yann Lecluse4, Nathalie Droin1, Beat Bornhauser5, Laurence C. Cheung3,9, John D. Crispino10, Muriel Gaudry1, Olivier A. Bernard1, Elizabeth Macintyre11, Carole Barin Bonnigal12, Rishi S. Kotecha3,9,13, Birgit Geoerger4, Paola Ballerini14, Jean-Pierre Bourquin5, Eric Delabesse6, Thomas Mercher1,15 and Sébastien Malinge1,3 1INSERM U1170, Gustave Roussy Institute, Université Paris Saclay, Villejuif, France 2Université Paris Diderot, Paris, France 3Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Australia 4Gustave Roussy Institute Cancer Campus, Department of Pediatric and Adolescent Oncology, INSERM U1015, Equipe Labellisée Ligue Nationale contre le Cancer, Université Paris-Saclay, Villejuif, France 5Department of Pediatric Oncology, Children’s Research Centre, University Children’s Hospital Zurich, Zurich, Switzerland 6Centre of Research on Cancer of Toulouse (CRCT), CHU Toulouse, Université Toulouse III, Toulouse, France 7IGBMC, Plateforme GenomEast, UMR7104 CNRS, Ilkirch, France 8Service de Génétique, Institut Curie, Paris, France 9School of Pharmacy and Biomedical Sciences, Curtin University, Bentley, Australia 10Division of Hematology/Oncology, Northwestern University, Chicago, USA 11Hematology, Université de Paris, Institut Necker-Enfants Malades and Assistance Publique – Hopitaux de Paris, Paris, France 12Centre Hospitalier Universitaire de Tours, Tours, France 1 Downloaded from clincancerres.aacrjournals.org on September 30, 2021.
    [Show full text]
  • Entrez Symbols Name Termid Termdesc 117553 Uba3,Ube1c
    Entrez Symbols Name TermID TermDesc 117553 Uba3,Ube1c ubiquitin-like modifier activating enzyme 3 GO:0016881 acid-amino acid ligase activity 299002 G2e3,RGD1310263 G2/M-phase specific E3 ubiquitin ligase GO:0016881 acid-amino acid ligase activity 303614 RGD1310067,Smurf2 SMAD specific E3 ubiquitin protein ligase 2 GO:0016881 acid-amino acid ligase activity 308669 Herc2 hect domain and RLD 2 GO:0016881 acid-amino acid ligase activity 309331 Uhrf2 ubiquitin-like with PHD and ring finger domains 2 GO:0016881 acid-amino acid ligase activity 316395 Hecw2 HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 GO:0016881 acid-amino acid ligase activity 361866 Hace1 HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1 GO:0016881 acid-amino acid ligase activity 117029 Ccr5,Ckr5,Cmkbr5 chemokine (C-C motif) receptor 5 GO:0003779 actin binding 117538 Waspip,Wip,Wipf1 WAS/WASL interacting protein family, member 1 GO:0003779 actin binding 117557 TM30nm,Tpm3,Tpm5 tropomyosin 3, gamma GO:0003779 actin binding 24779 MGC93554,Slc4a1 solute carrier family 4 (anion exchanger), member 1 GO:0003779 actin binding 24851 Alpha-tm,Tma2,Tmsa,Tpm1 tropomyosin 1, alpha GO:0003779 actin binding 25132 Myo5b,Myr6 myosin Vb GO:0003779 actin binding 25152 Map1a,Mtap1a microtubule-associated protein 1A GO:0003779 actin binding 25230 Add3 adducin 3 (gamma) GO:0003779 actin binding 25386 AQP-2,Aqp2,MGC156502,aquaporin-2aquaporin 2 (collecting duct) GO:0003779 actin binding 25484 MYR5,Myo1e,Myr3 myosin IE GO:0003779 actin binding 25576 14-3-3e1,MGC93547,Ywhah
    [Show full text]
  • Supplementary Information Integrative Analyses of Splicing in the Aging Brain: Role in Susceptibility to Alzheimer’S Disease
    Supplementary Information Integrative analyses of splicing in the aging brain: role in susceptibility to Alzheimer’s Disease Contents 1. Supplementary Notes 1.1. Religious Orders Study and Memory and Aging Project 1.2. Mount Sinai Brain Bank Alzheimer’s Disease 1.3. CommonMind Consortium 1.4. Data Availability 2. Supplementary Tables 3. Supplementary Figures Note: Supplementary Tables are provided as separate Excel files. 1. Supplementary Notes 1.1. Religious Orders Study and Memory and Aging Project Gene expression data1. Gene expression data were generated using RNA- sequencing from Dorsolateral Prefrontal Cortex (DLPFC) of 540 individuals, at an average sequence depth of 90M reads. Detailed description of data generation and processing was previously described2 (Mostafavi, Gaiteri et al., under review). Samples were submitted to the Broad Institute’s Genomics Platform for transcriptome analysis following the dUTP protocol with Poly(A) selection developed by Levin and colleagues3. All samples were chosen to pass two initial quality filters: RNA integrity (RIN) score >5 and quantity threshold of 5 ug (and were selected from a larger set of 724 samples). Sequencing was performed on the Illumina HiSeq with 101bp paired-end reads and achieved coverage of 150M reads of the first 12 samples. These 12 samples will serve as a deep coverage reference and included 2 males and 2 females of nonimpaired, mild cognitive impaired, and Alzheimer's cases. The remaining samples were sequenced with target coverage of 50M reads; the mean coverage for the samples passing QC is 95 million reads (median 90 million reads). The libraries were constructed and pooled according to the RIN scores such that similar RIN scores would be pooled together.
    [Show full text]
  • The Roles of Histone Deacetylase 5 and the Histone Methyltransferase Adaptor WDR5 in Myc Oncogenesis
    The Roles of Histone Deacetylase 5 and the Histone Methyltransferase Adaptor WDR5 in Myc oncogenesis By Yuting Sun This thesis is submitted in fulfilment of the requirements for the degree of Doctor of Philosophy at the University of New South Wales Children’s Cancer Institute Australia for Medical Research School of Women’s and Children’s Health, Faculty of Medicine University of New South Wales Australia August 2014 PLEASE TYPE THE UNIVERSITY OF NEW SOUTH WALES Thesis/Dissertation Sheet Surname or Family name: Sun First name: Yuting Other name/s: Abbreviation for degree as given in the University calendar: PhD School : School of·Women's and Children's Health Faculty: Faculty of Medicine Title: The Roles of Histone Deacetylase 5 and the Histone Methyltransferase Adaptor WDR5 in Myc oncogenesis. Abstract 350 words maximum: (PLEASE TYPE) N-Myc Induces neuroblastoma by regulating the expression of target genes and proteins, and N-Myc protein is degraded by Fbxw7 and NEDD4 and stabilized by Aurora A. The class lla histone deacetylase HDAC5 suppresses gene transcription, and blocks myoblast and leukaemia cell differentiation. While histone H3 lysine 4 (H3K4) trimethylation at target gene promoters is a pre-requisite for Myc· induced transcriptional activation, WDRS, as a histone H3K4 methyltransferase presenter, is required for H3K4 methylation and transcriptional activation mediated by a histone H3K4 methyltransferase complex. Here, I investigated the roles of HDAC5 and WDR5 in N-Myc overexpressing neuroblastoma. I have found that N-Myc upregulates HDAC5 protein expression, and that HDAC5 represses NEDD4 gene expression, increases Aurora A gene expression and consequently upregulates N-Myc protein expression in neuroblastoma cells.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Identification of Potential Markers for Type 2 Diabetes Mellitus Via Bioinformatics Analysis
    1868 MOLECULAR MEDICINE REPORTS 22: 1868-1882, 2020 Identification of potential markers for type 2 diabetes mellitus via bioinformatics analysis YANA LU1, YIHANG LI1, GUANG LI1* and HAITAO LU2* 1Key Laboratory of Dai and Southern Medicine of Xishuangbanna Dai Autonomous Prefecture, Yunnan Branch, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Jinghong, Yunnan 666100; 2Key Laboratory of Systems Biomedicine, Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai 200240, P.R. China Received March 20, 2019; Accepted January 20, 2020 DOI: 10.3892/mmr.2020.11281 Abstract. Type 2 diabetes mellitus (T2DM) is a multifactorial and cell proliferation’. These candidate genes were also involved in multigenetic disease, and its pathogenesis is complex and largely different signaling pathways associated with ‘PI3K/Akt signaling unknown. In the present study, microarray data (GSE201966) of pathway’, ‘Rap1 signaling pathway’, ‘Ras signaling pathway’ β-cell enriched tissue obtained by laser capture microdissection and ‘MAPK signaling pathway’, which are highly associated were downloaded, including 10 control and 10 type 2 diabetic with the development of T2DM. Furthermore, a microRNA subjects. A comprehensive bioinformatics analysis of microarray (miR)-target gene regulatory network and a transcription data in the context of protein-protein interaction (PPI) networks factor-target gene regulatory network were constructed based was employed, combined with subcellular location information on miRNet and NetworkAnalyst databases, respectively. to mine the potential candidate genes for T2DM and provide Notably, hsa-miR‑192-5p, hsa-miR‑124-5p and hsa-miR‑335-5p further insight on the possible mechanisms involved. First, appeared to be involved in T2DM by potentially regulating the differential analysis screened 108 differentially expressed expression of various candidate genes, including procollagen genes.
    [Show full text]
  • Primate Specific Retrotransposons, Svas, in the Evolution of Networks That Alter Brain Function
    Title: Primate specific retrotransposons, SVAs, in the evolution of networks that alter brain function. Olga Vasieva1*, Sultan Cetiner1, Abigail Savage2, Gerald G. Schumann3, Vivien J Bubb2, John P Quinn2*, 1 Institute of Integrative Biology, University of Liverpool, Liverpool, L69 7ZB, U.K 2 Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, The University of Liverpool, Liverpool L69 3BX, UK 3 Division of Medical Biotechnology, Paul-Ehrlich-Institut, Langen, D-63225 Germany *. Corresponding author Olga Vasieva: Institute of Integrative Biology, Department of Comparative genomics, University of Liverpool, Liverpool, L69 7ZB, [email protected] ; Tel: (+44) 151 795 4456; FAX:(+44) 151 795 4406 John Quinn: Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, The University of Liverpool, Liverpool L69 3BX, UK, [email protected]; Tel: (+44) 151 794 5498. Key words: SVA, trans-mobilisation, behaviour, brain, evolution, psychiatric disorders 1 Abstract The hominid-specific non-LTR retrotransposon termed SINE–VNTR–Alu (SVA) is the youngest of the transposable elements in the human genome. The propagation of the most ancient SVA type A took place about 13.5 Myrs ago, and the youngest SVA types appeared in the human genome after the chimpanzee divergence. Functional enrichment analysis of genes associated with SVA insertions demonstrated their strong link to multiple ontological categories attributed to brain function and the disorders. SVA types that expanded their presence in the human genome at different stages of hominoid life history were also associated with progressively evolving behavioural features that indicated a potential impact of SVA propagation on a cognitive ability of a modern human.
    [Show full text]
  • Genome-Wide Association and Transcriptome Studies Identify Candidate Genes and Pathways for Feed Conversion Ratio in Pigs
    Miao et al. BMC Genomics (2021) 22:294 https://doi.org/10.1186/s12864-021-07570-w RESEARCH ARTICLE Open Access Genome-wide association and transcriptome studies identify candidate genes and pathways for feed conversion ratio in pigs Yuanxin Miao1,2,3, Quanshun Mei1,2, Chuanke Fu1,2, Mingxing Liao1,2,4, Yan Liu1,2, Xuewen Xu1,2, Xinyun Li1,2, Shuhong Zhao1,2 and Tao Xiang1,2* Abstract Background: The feed conversion ratio (FCR) is an important productive trait that greatly affects profits in the pig industry. Elucidating the genetic mechanisms underpinning FCR may promote more efficient improvement of FCR through artificial selection. In this study, we integrated a genome-wide association study (GWAS) with transcriptome analyses of different tissues in Yorkshire pigs (YY) with the aim of identifying key genes and signalling pathways associated with FCR. Results: A total of 61 significant single nucleotide polymorphisms (SNPs) were detected by GWAS in YY. All of these SNPs were located on porcine chromosome (SSC) 5, and the covered region was considered a quantitative trait locus (QTL) region for FCR. Some genes distributed around these significant SNPs were considered as candidates for regulating FCR, including TPH2, FAR2, IRAK3, YARS2, GRIP1, FRS2, CNOT2 and TRHDE. According to transcriptome analyses in the hypothalamus, TPH2 exhibits the potential to regulate intestinal motility through serotonergic synapse and oxytocin signalling pathways. In addition, GRIP1 may be involved in glutamatergic and GABAergic signalling pathways, which regulate FCR by affecting appetite in pigs. Moreover, GRIP1, FRS2, CNOT2,andTRHDE may regulate metabolism in various tissues through a thyroid hormone signalling pathway.
    [Show full text]
  • Gene and Pathway-Based Second-Wave Analysis of Genome-Wide Association Studies
    European Journal of Human Genetics (2010) 18, 111–117 & 2010 Macmillan Publishers Limited All rights reserved 1018-4813/10 $32.00 www.nature.com/ejhg ARTICLE Gene and pathway-based second-wave analysis of genome-wide association studies Gang Peng1, Li Luo2, Hoicheong Siu1, Yun Zhu1, Pengfei Hu1, Shengjun Hong1, Jinying Zhao3, Xiaodong Zhou4, John D Reveille4, Li Jin1, Christopher I Amos5 and Momiao Xiong*,2 Despite the great success of genome-wide association studies (GWAS) in identification of the common genetic variants associated with complex diseases, the current GWAS have focused on single-SNP analysis. However, single-SNP analysis often identifies only a few of the most significant SNPs that account for a small proportion of the genetic variants and offers only a limited understanding of complex diseases. To overcome these limitations, we propose gene and pathway-based association analysis as a new paradigm for GWAS. As a proof of concept, we performed a comprehensive gene and pathway-based association analysis of 13 published GWAS. Our results showed that the proposed new paradigm for GWAS not only identified the genes that include significant SNPs found by single-SNP analysis, but also detected new genes in which each single SNP conferred a small disease risk; however, their joint actions were implicated in the development of diseases. The results also showed that the new paradigm for GWAS was able to identify biologically meaningful pathways associated with the diseases, which were confirmed by a gene-set-rich analysis using gene expression
    [Show full text]